Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Molecular Cancer Therapeutics|October 24, 2022
Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal CancerHajrah Khawaja, Rebecca Briggs, Cheryl H Latimer, et al.
JCO Clinical Cancer Informatics|April 18, 2019
A Machine Learning Platform to Optimize the Translation of Personalized Network Models to the ClinicManuela Salvucci, Arman Rahman, Alexa J Resler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2021
Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populationsXanthi Stachtea, Maurice B Loughrey, Manuela Salvucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2016
Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal CancerPhilip D Dunne, Darragh G McArt, Conor A Bradley, et al.
Gut|September 25, 2016
BCL-2 system analysis identifies high-risk colorectal cancer patientsAndreas U Lindner, Manuela Salvucci, Clare Morgan, et al.
Cell Death and Differentiation|November 10, 2021
An atlas of inter- and intra-tumor heterogeneity of apoptosis competency in colorectal cancer tissue at single-cell resolutionAndreas Ulrich Lindner, Manuela Salvucci, Elizabeth McDonough, et al.
BJC Reports|March 27, 2025
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancersPeter Gallagher, Christian Rolfo, Elena Elez, et al.
BMC Cancer|April 11, 2025
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)Francesca Aroldi, Elena Elez, Thierry André, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal CancerManuela Salvucci, Maximilian L Würstle, Clare Morgan, et al.
Nature Metabolism|July 23, 2026
Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancerDeborah Y Moss, Connor N Brown, Andrew M Shaw, et al.
Pageof 5